Elizabeth Bilsland
Universidade Estadual de Campinas (UNICAMP), University of Cambridge
Papers
3
Total Citations
245
H-Index
2
About
Elizabeth Bilsland is a pioneering researcher at the intersection of drug discovery, systems biology, and neglected tropical diseases. Her work centers on developing innovative, cost-effective strategies to accelerate pharmaceutical development, particularly for diseases that lack commercial incentives. Her most impactful contribution is the creation of the Robot Scientist 'Eve', an artificial intelligence-driven platform that automates and expedites drug screening. This breakthrough, detailed in her highly cited 2015 paper (161 citations), demonstrated the power of automated drug repositioning, offering a cheaper, faster route to treatments for neglected and orphan diseases. Bilsland has also made fundamental contributions to our understanding of cellular drug uptake. Her 2011 study (82 citations) used a yeast model to systematically map the carriers involved in drug transport, challenging the long-held assumption of passive diffusion and revealing a predominantly carrier-mediated process. More recently, she has applied her expertise to target-based drug screening, developing a yeast platform to identify inhibitors of *Plasmodium vivax* deoxyhypusine synthase, a promising antimalarial target. Through her integration of robotics, genomics, and pharmacology, Bilsland is not only advancing drug discovery for underserved diseases but also reshaping our fundamental understanding of how drugs enter cells.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3